机构:[1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[2]Department of Pulmonary Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362100, China.[3]Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.四川大学华西医院[4]Department of Respiratory Medicine, Daping Hospital, Chongqing 400042, China.[5]Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.[6]Department of Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.[7]Department of Thoracic Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.[8]Department of Medical Oncology, Hunan Cancer Hospital, Changsha 410006, China.[9]Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China.[10]Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.[11]Burning Rock Biotech, Guangzhou 510300, China.[12]Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.华中科技大学同济医学院附属同济医院
第一作者机构:[1]Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
推荐引用方式(GB/T 7714):
Hu Xingsheng,Yang Dongyong,Li Yalun,et al.Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.[J].Cancer Biology & Medicine.2020,17(2):513.doi:10.20892/j.issn.2095-3941.2020.0029.
APA:
Hu Xingsheng,Yang Dongyong,Li Yalun,Li Li,Wang Yan...&Hu Chengping.(2020).Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients..Cancer Biology & Medicine,17,(2)
MLA:
Hu Xingsheng,et al."Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.".Cancer Biology & Medicine 17..2(2020):513